Navigating Uncleared Margin Rules

(CME Group Partner Content) – Since Uncleared Margin Rules (UMR) went live in 2016, only a small number of firms have been impacted by Phases 1-4. But by September 2021, an estimated 1,000+ additional firms will be subject to UMR for initial margin. These firms must get ready to comply with new regulatory initial margin and reporting requirements on non-centrally cleared OTC derivatives.
Initial margin (IM) is collateral posted to help reduce risk exposure to a given counterparty. Posting IM is a new step for many firms trading non-cleared OTC derivatives, and will increase a firm’s costs.

The resources here can help you understand if, when and how your firm will be impacted by UMR for IM in Phases 5 & 6. If your firm is in scope, CME Group offers the broadest set of global solutions to help you overcome UMR challenges. How? By minimizing UMR exposure, easing the burden of daily requirements, and reducing your notional outstanding and IM amounts.

Read the full article here: Navigating Uncleared Margin Rules – Find Capital-Efficient Solutions to UMR Challenges

Picture: (c) By-Anikin-Denis—shutterstock.com